Stage IVB Colorectal Cancer Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095781Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerTreatment
NCT02298959Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid TumorsTreatment
NCT02837263PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal CancerTreatment